Skip to main content
. 2021 Jul 23;4:906. doi: 10.1038/s42003-021-02381-x

Fig. 5. Immune cell heterogeneity for the various lung cancer treatments in mice.

Fig. 5

Heterogeneity of total CD45+ TILs from lung tumors all together (A) and separately under five different treatment conditions (Control, Adjuvant, CA170, KVAX vaccine and the combination of CA170 peptide plus KVAX vaccine) (B) in lung cancer shown by UMAP. C Feature plot shows representative genes for the different types of immune cells: CD4+, CD8+, B cells (Cd19), NK cells (Ncr1), Tregs (Foxp3), and Myeloid cell-specific genes (Cd3e, Itgam, Itgax, Csf1r) across all clusters for the five treatment conditions. D The bar plot shows the percentage of different immune cells under five different treatment conditions individually.